Products

AI Highlights
CapsoVision
Gastroenterology AI
AI Highlights is an AI-assisted reading tool for the CapsoCam Plus capsule endoscopy system, designed to reduce the time physicians spend reviewing small bowel capsule endoscopy studies by identifying and prioritizing images with suspected abnormal lesions.

See all 1 product →

About CapsoVision

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7]

Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing a comprehensive 360° panoramic view of the small bowel mucosa. [3, 9, 24] Unlike traditional capsule endoscopes, the CapsoCam Plus eliminates the need for sensor belts or vests, allowing for comfortable at-home ingestion and expanding patient access. [3, 7] The capsule records and stores video images in its onboard memory as it travels through the GI tract. [7, 18, 22] Healthcare providers can then review these images using CapsoCloud, a secure cloud-based platform for streaming and storage, or CapsoView software. [7, 22, 26] The CapsoCam Plus is a Class II device with FDA 510(k) clearance, including expanded pediatric clearance for children as young as two years old as of January 2025. [3, 7]

CapsoVision is also actively developing an AI-enhanced version of CapsoCam Plus, featuring self-developed algorithms for automatic detection of polyps, lesions, and bleeding sites, with FDA submission targeted for the second half of 2025. [3] They are also working on a next-generation colon capsule, CapsoCam Colon, powered by advanced AI-driven polyp detection, designed for non-invasive colon imaging. [15, 16, 23] The company’s long-term vision includes an ingestible capsule capable of screening for multiple GI cancers at early stages, utilizing AI to analyze thousands of images. [23]

Focus Areas

GI capsule imaging systems digital imaging devices for medical applications diagnosis of small bowel diseases (including bleeding cancer celiac and Crohn's disease) AI integration for automatic detection of polyps lesions and bleeding sites cloud-based clinical data management telehealth-enabled diagnostic workflows non-invasive colon imaging and screening for multiple GI cancers. [1 3 7 9 13 16 23]

Business Intelligence

Key InvestorsStar One Global Capital Limited, Eliyahou Harari
PartnershipsABS-Bolton Medical (France), Shaili Endoscopy (India and Sri Lanka), Nicolai (Germany), Northwest Health
Acquisitionsunknown
TechnologyCapsoCam Plus® (multi-camera panoramic in vivo imaging capsule with onboard flash memory), CapsoCloud® (cloud-native platform for workflow and data management), CapsoView® (clinical image review and annotation software), AI Highlights (AI-assisted reading tool)
FDA Clearancesunknown cleared products (estimated)

What Physicians Need to Know

GI Capsule Imaging Systems
CapsoVision specializes in advanced GI capsule imaging systems, notably the CapsoCam Plus®, which offers a 360° panoramic lateral view of the small bowel mucosa. This system utilizes four high-resolution cameras and onboard flash memory storage, eliminating the need for external receiver equipment. [1, 7, 10, 23]
Diagnosis of Small Bowel Diseases
Their technology is used for the diagnosis of various small bowel diseases, including obscure GI bleeding, Crohn's disease, celiac disease, and the detection of small bowel tumors. [1, 9, 20, 22, 26]
AI Integration for Detection
CapsoVision integrates AI for automatic detection of polyps, lesions, and bleeding sites. Their AI Highlights feature, cleared by the FDA for suspected small bowel bleeding, identifies and prioritizes frames with suspected abnormal lesions to reduce review time for physicians. [2, 6, 16, 19, 21, 30]
Cloud-Based Clinical Data Management
They offer CapsoCloud®, a secure, HIPAA-compliant, cloud-based platform for clinical data management, enabling convenient and cost-effective access to patient exam data anywhere, anytime. [1, 2, 5, 8, 13]
Telehealth-Enabled Diagnostic Workflows
CapsoVision supports telehealth-enabled diagnostic workflows, including remote ingestion of the CapsoCam Plus capsule under virtual supervision, enhancing patient accessibility and comfort. [1, 2, 4, 7, 24]
Non-Invasive Colon Imaging & Cancer Screening
CapsoVision is developing CapsoCam Colon™, powered by advanced AI-driven polyp detection, for non-invasive colon imaging and screening for multiple GI cancers. They are also pursuing a pancreatic cancer screening capsule. [6, 12, 15, 29]
Physician Tip

CapsoVision's CapsoCam Plus® system offers a comprehensive 360° panoramic view of the small bowel, potentially increasing diagnostic yield compared to traditional forward-facing capsules. [4, 7, 17] The wire-free design and remote ingestion capabilities streamline workflow and enhance patient comfort, reducing the need for external equipment and clinic visits. [4, 7, 10, 24] The CapsoCloud platform provides secure, anytime, anywhere access to patient data, facilitating efficient review and collaboration. [2, 7, 8, 17] The AI Highlights feature can significantly reduce reading time by automatically identifying and prioritizing suspected lesions, acting as a valuable aid in diagnosis. [2, 6, 16, 21, 30] CapsoVision also offers a third-party clinical reading service with board-certified gastroenterologists for outsourced reads. [1, 13] The system is FDA-cleared for use in adults and pediatric patients aged two years and older. [7, 12, 21]

CapsoVision's CapsoView® software for image review and annotation integrates with the CapsoCloud® platform, supporting AI-assisted review workflows. [2, 6, 8, 16, 21] The CapsoAccess system facilitates local data transfer from the capsule to a workstation for review with CapsoView. [8] CapsoVision's platform is built with a fully cloud-based architecture, eliminating the need for on-site servers and reducing IT maintenance burdens. [12] Data is stored on Amazon Web Services (AWS) with SOC2 and ISO/IEC 27001:2022 certifications, ensuring security. [2]

Products by CapsoVision

1 product in the directory

AI Highlights
CapsoVision
Gastroenterology AI
AI Highlights is an AI-assisted reading tool for the CapsoCam Plus capsule endoscopy system, designed to reduce the time physicians spend reviewing small bowel capsule endoscopy studies by identifying and prioritizing images with suspected abnormal lesions.

What the Web Says

CapsoVision appears to be a company with a mixed reputation. While their product, the CapsoCam Plus, is generally seen as innovative and effective for colon capsule endoscopy, the company culture and employee experience, particularly regarding management and work-life balance, receive significant criticism. There's a clear distinction between positive product reception and negative employer reviews.

Overall: Mixed

Strengths

  • Innovative technology (CapsoCam Plus)
  • Less invasive alternative to traditional endoscopy
  • High-quality images for diagnosis
  • Potential for improved patient comfort and compliance
  • Good for detecting polyps and abnormalities
  • Helpful customer support for product users

Limitations

  • Poor management and leadership within the company
  • High employee turnover
  • Lack of work-life balance for employees
  • Inadequate compensation and benefits for some roles
  • Limited career growth opportunities internally
  • Concerns about company culture and internal communication

Based on reviews from: Glassdoor, G2, Reddit, Capterra, Healthcare IT News

Last updated: 2026-10-16

Videos

News, demos, and interviews about CapsoVision.

Loading videos...

Videos load interactively. If none appear, search YouTube for CapsoVision →

View all on YouTube

Press & Coverage

GeneOnline News
CapsoVision Secures $14 Million in Private Placement Financing for Capsule Endoscopy Solutions
CapsoVision announced it secured $14 million in private placement financing to support ongoing operations and strategic initiatives in developing capsule endoscopy solutions.
2026-03
Stock Titan
CapsoVision raises $14M, refocuses GI pipeline
CapsoVision completed a $14 million private placement and is reallocating resources to a second-generation colon capsule with improved imaging and AI, following FDA feedback on its first-generation product.
2026-03
GlobeNewswire
CapsoVision® Announces International Launch of AI Highlights
CapsoVision announced the international launch of AI Highlights, an AI-assisted reading tool for its CapsoCam Plus system, designed to support physician review of small bowel capsule endoscopy studies.
2026-08
Dealroom News
CapsoVision raises $18M from existing shareholders in direct offering
CapsoVision raised $18 million through a registered direct stock offering to existing shareholders, with plans to use the capital for general corporate purposes including sales, marketing, and R&D.
2026-09
GlobeNewswire
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
CapsoVision announced that its AI Highlights, an AI-assisted reading tool for the CapsoCam Plus system, received FDA clearance on September 25, 2026, to aid physicians in reviewing small bowel capsule endoscopy studies.
2026-09
Investing.com
CapsoVision receives FDA clearance for AI reading tool
CapsoVision Inc. received FDA clearance for its AI Highlights reading tool, designed to assist physicians in reviewing small bowel capsule endoscopy studies by recognizing and marking suspected abnormal lesions.
2026-09
Stock Titan
CapsoVision to Present at the 20th Annual LD Micro Main Event
CapsoVision announced that its CEO, Johnny Wang, and other executives will present at the 20th Annual LD Micro Main Event, a significant investor conference.
2026-10
PMC (Frontiers in Medicine)
Clinical usefulness and acceptability of small‐bowel capsule endoscopy with panoramic imaging compared with axial imaging in Japanese patients
A study published in DEN Open in 2025 found that CapsoCam offered comparable detectability of bleeding sources and superior visualization of the entire small bowel and Vater's papillae compared to traditional axial imaging in Japanese patients.
2025-01

Frequently Asked Questions

CapsoVision primarily offers the CapsoCam Plus, a capsule endoscopy system designed for the diagnosis of small bowel diseases such as bleeding, Crohn's disease, celiac disease, and polyps. It provides 360-degree panoramic imaging without a magnetic receiver, aiming to enhance diagnostic yield and patient comfort compared to traditional endoscopy.
CapsoVision leverages AI algorithms to assist in the automatic detection of various abnormalities, including polyps, lesions, and bleeding sites within the GI tract. This AI integration is designed to improve the efficiency and accuracy of image review, potentially reducing physician workload and enhancing diagnostic precision.
CapsoVision utilizes a cloud-based platform for clinical data management, allowing for secure storage, access, and sharing of patient data and imaging results. This infrastructure facilitates telehealth-enabled diagnostic workflows by enabling remote review of capsule endoscopy studies and collaborative care among healthcare providers, improving accessibility and efficiency.
CapsoVision is developing technologies for non-invasive colon imaging, aiming to provide a less intrusive option for colorectal cancer screening. While specific products for colon imaging may be in various stages of development, the company's focus is on expanding its diagnostic capabilities to include broader GI cancer screening applications.
CapsoVision's pricing for its GI capsule imaging systems typically involves the cost of the capsules and associated software licenses, with variations depending on the volume and specific contractual agreements. The company generally provides comprehensive support, including initial training for medical staff, technical assistance, and ongoing customer service to ensure optimal system utilization and performance.
CapsoVision adheres to stringent regulatory compliance standards for medical devices, including FDA clearances and CE markings, to ensure the safety and efficacy of its products. For data security, the company implements robust encryption and privacy protocols within its cloud-based platforms to protect patient health information in accordance with HIPAA and other relevant data protection regulations.
CapsoVision has established partnerships with various healthcare providers, academic institutions, and technology companies to advance its GI diagnostic solutions and expand market reach. The company demonstrates stability through continuous innovation in capsule endoscopy and AI integration, with a long-term vision focused on becoming a leader in non-invasive GI imaging and early cancer detection.

Related Companies

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]

MedSafeAI is a medical AI workspace for doctors and other licensed healthcare professionals. It brings several AI model families into one place so clinicians can compare answers and check the evidence behind them, instead of relying on a single model. Ask All AI puts answers from multiple model families side by side, and Consensus AI […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.